<http://schema.org/description>
"The trial conducted by the Radiation Therapy Oncology Group (RTOG) shows the feasibility to deliver bevacizumab to the current chemoradiation standard without any apparent increased adverse side effects."^^<http://www.w3.org/2001/XMLSchema#string>
<http://medicalxpress.com/news/2011-12-nasopharyngeal-carcinoma-bevacizumab-phase-trial.html>